Journal article icon

Journal article

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Abstract:

Background

Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features ... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's Version

Actions


Access Document


Files:
Publisher copy:
10.1016/s1474-4422(19)30184-x

Authors


Expand authors...
Publisher:
Elsevier Publisher's website
Journal:
Lancet Neurology Journal website
Volume:
18
Issue:
7
Pages:
643–52
Publication date:
2019-05-22
DOI:
EISSN:
1474-4465
ISSN:
1474-4422
Pubs id:
pubs:1019792
URN:
uri:66f71a54-b592-471a-bf9f-a98fc9be6fa5
UUID:
uuid:66f71a54-b592-471a-bf9f-a98fc9be6fa5
Local pid:
pubs:1019792
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP